Stocks · Health care · Biological Products, (No Diagnostic Substances)

Vir Biotechnology, Inc.

VIR Clue Score34
United States Fiscal year ends December CIK 0001706431 Results filed 4 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Verneuil Vanina de
3 Nov 2026
EVP, General Counsel, Corp Sec
Sold on a plan
2,407
$11.10
$26.72K
Verneuil Vanina de
2 Nov 2026
EVP, General Counsel, Corp Sec
Sold on a plan
1,343
$11.33
$15.22K

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 12,731
History held since 10 Oct 2019